Treatment of severe falciparum malaria: quinine versus artesunate
Journal: International Journal of Basic & Clinical Pharmacology (Vol.2, No. 1)Publication Date: 2013-02-01
Authors : Dipesh Patel Vishal Sadatia Mehul Patel;
Page : 30-36
Keywords : Severe falciparum malaria; Quinine; Artesunate;
Abstract
Background: Malaria is the most important disease of human being. More than 40% of the world’s population is considered to be at risk of exposure of this disease. Malaria infection has been increasing over recent years due to combination of factors including increasing resistance of malarial parasite. Most of the strains of P. falciparum are now resistance to conventional drugs like chloroquine in many areas. The objective of this study was to compare the efficacy and safety of quinine and artesunate in treatment of P. falciparum malaria. Methods: This is hospital based prospective study, conducted amongst 35 randomly selected patients of severe P. falciparum malaria. Patients with any contraindications of either drug were excluded to avoid bias. Standard statistical tests were applied for qualitative as well as quantitative data. Results: As per the study end point results of difference of mortality in patients receiving either drug was not significant (p > 0.75), but difference in clinical parameters like fever clearance time (p
Other Latest Articles
- Haemodynamic effects of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesia
- Comparative effectiveness study of vinpocetine vs. nimodipine on functional recovery in patients of head injury
- Use of polycarbonate plastic products and human health
- Newer drugs in the management of diabetes mellitus
- Challenges to rational prescribing and use of essential medicines in India
Last modified: 2013-03-02 19:16:16